Filter Results:
(230)
Show Results For
- All HBS Web
(230)
- News (63)
- Research (126)
- Events (1)
- Multimedia (15)
- Faculty Publications (68)
Show Results For
- All HBS Web
(230)
- News (63)
- Research (126)
- Events (1)
- Multimedia (15)
- Faculty Publications (68)
- 11 Sep 2007
- First Look
First Look: September 11, 2007
also—and crucially so—on whether or not the platforms subsidize one side of the market in equilibrium. For example, with prices being strategic complements across platforms, we show that a cost-reducing investment by one firm may have a... View Details
Keywords: Martha Lagace
- 2007
- Other Unpublished Work
A Private Sector without Prerequisites: Ordered Uncertainty in Vietnam and China
By: Regina M. Abrami
- Article
Transparency as a Solution for the Hospital Capacity Problem
COVID dramatically clarified a shortcoming in our great healthcare system, but like everything in the world, it has its shortcomings. What we see through the apex of COVID is that many hospitals in hotspot areas cannot provide an adequate supply of beds. Although the... View Details
Herzlinger, Regina E. "Transparency as a Solution for the Hospital Capacity Problem." Ohio State Law Journal 82, no. 5 (December 2021): 787–794.
- 2015
- Other Teaching and Training Material
Innovating in Healthcare
By: Regina E. Herzlinger, Margo I. Seltzer and Kevin Schulman
With over 71,000 past enrollees, Innovating in Healthcare investigates the issues of health care spending, quality, and access that continue to plague America and global nations alike. With U.S. health care costs trending toward $4 trillion in 2020, the need to... View Details
Herzlinger, Regina E., Margo I. Seltzer, and Kevin Schulman. "Innovating in Healthcare." edX Inc., 2015. Video. (HarvardX Massive Open Online Course.)
- May 2018 (Revised October 2020)
- Supplement
La Ribera Health Department (B): Epilogue
By: Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer
The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy... View Details
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Pharmaceutical Industry; Health Industry; Retail Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- July 1996 (Revised August 2024)
- Case
Innovative Opportunities to Manage Health Care Delivery
By: Regina E. Herzlinger and D. Scott Lurding
The purpose of this case is:
To familiarize the students with the changing landscape of health care delivery, through chains of retail medical centers and those offering value-based care (VBC).
To discuss fundamental managerial decisions about their... View Details
To discuss fundamental managerial decisions about their... View Details
Herzlinger, Regina E., and D. Scott Lurding. "Innovative Opportunities to Manage Health Care Delivery." Harvard Business School Case 197-011, July 1996. (Revised August 2024.)
- Web
2024 Reunion Presentations - Alumni
and the strategic challenges faced by business leaders and regulators alike. Slides Three Ways to Innovate Health Care Professor Regina Herzlinger (DBA 1971) 10:00–11:15 a.m. EDT + More Info – Less Info The... View Details
- January 2008 (Revised December 2011)
- Case
Inner Mongolia Yili Group: China's Pioneering Dairy Brand
By: Regina M. Abrami, William C. Kirby, F. Warren McFarlan and Tracy Yuen Manty
Setting up the goal to become one of the top 20 enterprises in the world dairy industry by 2010, the Inner Mongolia Yili Group had ambitious plans. As one of China's biggest national dairy companies, its main challenge was competing as a local company against... View Details
Keywords: Global Strategy; Globalized Markets and Industries; Growth and Development Strategy; Brands and Branding; Competition; Agriculture and Agribusiness Industry; China
Abrami, Regina M., William C. Kirby, F. Warren McFarlan, and Tracy Yuen Manty. "Inner Mongolia Yili Group: China's Pioneering Dairy Brand." Harvard Business School Case 308-052, January 2008. (Revised December 2011.)
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- September 2014 (Revised March 2021)
- Case
La Ribera Health Department (A)
By: Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer
The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy... View Details
Keywords: Health Care; Health Care Financing; Health Care Industry; Health Care Operations; Health Care and Treatment; Operations; Business Model; Government and Politics; Programs; Innovation Strategy; Vertical Integration; Health Industry; Europe; Spain
Herzlinger, Regina E., Emer Moloney, and Daniela Beyersdorfer. "La Ribera Health Department (A)." Harvard Business School Case 315-006, September 2014. (Revised March 2021.)
- December 2023
- Article
Association of Hospital System Affiliation with COVID-19 Capacity Burden
By: Zachary Levin, Pinar Karaca-Mandic, Richard J. Boxer and Regina E. Herzlinger
What is the message? The COVID-19 pandemic exposed the highly variable and uncoordinated responses by hospitals. The authors found that while the non-top ten system affiliated hospitals had a larger COVID-19 share index relative to independent hospitals, top-ten system... View Details
Keywords: COVID-19 Pandemic; Resource Allocation; Health Pandemics; Demographics; Health Care and Treatment; Health Industry
Levin, Zachary, Pinar Karaca-Mandic, Richard J. Boxer, and Regina E. Herzlinger. "Association of Hospital System Affiliation with COVID-19 Capacity Burden." Health Management, Policy and Innovation 8, no. 3 (December 2023).
- February 18, 2022
- Article
Transparency as a Solution for COVID-19 Related Hospital Capacity Issues
By: Regina E. Herzlinger and Richard Boxer
In the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide an adequate supply of beds to meet demand. Solving the problem of hospital bed capacity is of great importance in the “new normal,” which requires recognizing that SARS-CoV-2 is but... View Details
Keywords: COVID; COVID-19 Pandemic; Health Care; Health Care Demand; Health Care Delivery; Health Care Industry; Health Care Operations; Health Care Policy; Transparency; Hospital; Hospital Management; Hospitals; Health Pandemics; Health Care and Treatment; Service Delivery; Operations; Performance Capacity; Policy; Health Industry
Herzlinger, Regina E., and Richard Boxer. "Transparency as a Solution for COVID-19 Related Hospital Capacity Issues." Health Affairs Forefront (February 18, 2022).
- February 2010
- Case
Real Blue? Viagra and Intellectual Property Rights Law in China
By: Regina M. Abrami and Tracy Manty
On July 5, 2004, Pfizer's China team received disappointing news. China's patent review board just invalidated the company's existing patent on one of its most successful drugs, Viagra. Making matters worse, a Guangdong-based pharmaceutical company laid claim to... View Details
Keywords: Trade; International Relations; Patents; Trademarks; Lawsuits and Litigation; Rights; Business and Government Relations; Pharmaceutical Industry; China
Abrami, Regina M., and Tracy Manty. "Real Blue? Viagra and Intellectual Property Rights Law in China." Harvard Business School Case 910-409, February 2010.
- 01 Dec 2020
- News
Digital Health Care: Empowering Consumers
Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration, has been studying the health care sector for nearly half a century. In that time, she has seen significant innovation in the field—and she has also seen the... View Details
Keywords: April White
- 25 Jan 2011
- First Look
First Look: Jan. 25
grow and become successful, they are often marked by the negative stigma associated with size and power, which elicits anticorporate sentiment from consumers. An underdog brand biography can be strategically wielded to prevent or offset... View Details
Keywords: Sean Silverthorne
- 2008
- Chapter
Southeast Asia and the Political Economy of Development
By: Regina M. Abrami and Richard Doner
This chapter assesses contemporary qualitative research on Southeast Asia and its contribution to the field of political economy. It focuses especially on the political origins of economic institutions and their influence on economic performance. It provides evidence... View Details
Keywords: Development Economics; Entrepreneurship; Government and Politics; Research; Southeast Asia
Abrami, Regina M., and Richard Doner. "Southeast Asia and the Political Economy of Development." In Southeast Asia in Political Science: Theory, Region, and Qualitative Analysis, edited by Erik Martinez Kuhonta, Dan Slater, and Tuong Vu. Stanford University Press, 2008.
- 24 Apr 2014
- News
Addressing roadblocks to innovation in health care
Innovation in health care is a national and international priority driven by demand for quality and universal access, yet it has proved very difficult to achieve. Regina E. Herzlinger, the Nancy R. McPherson... View Details
- 07 Aug 2012
- First Look
First Look: August 7
experiment to measure the value of shareholder proxy access. We find that firms that would have been most vulnerable to proxy access, as measured by institutional ownership and activist institutional ownership in particular, lost value on... View Details
Keywords: Sean Silverthorne
- 10 Jul 2018
- First Look
New Research and Ideas, July 10, 2018
investors shapes information diffusion in the stock market. We exploit trade-level data to show that central brokers gather information by executing informed trades, which is then leaked to their best clients. We show that after large... View Details
Keywords: Dina Gerdeman